Month: February 2022

New treatment approved for late-stage prostate cancer

In late March, the FDA approved a new therapy for advanced prostate cancer that is metastasizing, or spreading, in the body. Called Pluvicto (and also lutetium-177-PSMA-617), and delivered by intravenous infusion, the treatment can seek out and destroy tumors that are still too small to see with conventional types of medical imaging. Pluvicto is approved …

New treatment approved for late-stage prostate cancer Read More »

Blood donations are down — so why restrict blood donors by sexual orientation?

The blood supply in the US is critically low. Donations dropped off so dramatically during the COVID-19 pandemic that the American Red Cross has declared a national blood crisis. And since donated red blood cells only last about six weeks, supplies cannot be stockpiled in advance. A severe shortage could require difficult decisions about who …

Blood donations are down — so why restrict blood donors by sexual orientation? Read More »